List of Contents

Process Chromatography Market Size, Share, and Trends 2024 to 2034

The global process chromatography market size accounted for USD 14.62 billion in 2024, grew to USD 15.85 billion in 2025 and is projected to surpass around USD 32.76 billion by 2034, representing a healthy CAGR of 8.40% between 2024 and 2034. The North America process chromatography market size is calculated at USD 5.26billion in 2024 and is expected to grow at a fastest CAGR of 8.41% during the forecast year.

  • Last Updated : October 2024
  • Report Code : 3446
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Process Chromatography Market 

5.1. COVID-19 Landscape: Process Chromatography Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Process Chromatography Market, By Product

8.1. Process Chromatography Market, by Product, 2024-2034

8.1.1 Process Chromatography

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Preparative Chromatography

8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Process Chromatography Market, By Type

9.1. Process Chromatography Market, by Type, 2024-2034

9.1.1. Liquid Chromatography

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Gas Chromatography

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Thin Layer Chromatography

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Paper Chromatography

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Gel-permeation (Molecular Sieve) Chromatography

9.1.5.1. Market Revenue and Forecast (2021-2034)

9.1.6. Hydrophobic Interaction Chromatography

9.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Process Chromatography Market, By End Use 

10.1. Process Chromatography Market, by End Use, 2024-2034

10.1.1. Pharmaceutica

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Biotechnology

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Food

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Nutraceutical

10.1.4.1. Market Revenue and Forecast (2021-2034)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Process Chromatography Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.2. Market Revenue and Forecast, by Type (2021-2034)

11.1.3. Market Revenue and Forecast, by End Use (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Type (2021-2034)

11.1.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Type (2021-2034)

11.1.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.2. Market Revenue and Forecast, by Type (2021-2034)

11.2.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Type (2021-2034)

11.2.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Type (2021-2034)

11.2.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Type (2021-2034)

11.2.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Type (2021-2034)

11.2.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.2. Market Revenue and Forecast, by Type (2021-2034)

11.3.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Type (2021-2034)

11.3.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Type (2021-2034)

11.3.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Type (2021-2034)

11.3.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Type (2021-2034)

11.3.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.2. Market Revenue and Forecast, by Type (2021-2034)

11.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Type (2021-2034)

11.4.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Type (2021-2034)

11.4.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Type (2021-2034)

11.4.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Type (2021-2034)

11.4.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.2. Market Revenue and Forecast, by Type (2021-2034)

11.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Type (2021-2034)

11.5.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Type (2021-2034)

11.5.5.3. Market Revenue and Forecast, by End Use (2021-2034)

Chapter 12. Company Profiles

12.1. GE Healthcare Life Sciences

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Merck KGaA

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Thermo Fisher Scientific

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Agilent Technologies

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Bio-Rad Laboratories

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Waters Corporation

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Shimadzu Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Pall Corporation

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. PerkinElmer, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Novasep

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client